Judah Frommer
Stock Analyst at Morgan Stanley
(5)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics | Initiates Coverage On: Overweight | 18 | 7.58 | 137.47% | 1 | Aug 21, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Equal-Weight | 25 26 | 27.95 | -6.98% | 2 | Jul 2, 2025 | |
BPMC Blueprint Medicines | Maintains: Equal-Weight | 102 129 | 129.46 | -0.36% | 2 | Jun 5, 2025 | |
CLDX Celldex Therapeutics | Maintains: Overweight | 46 43 | 22.57 | 90.52% | 2 | May 9, 2025 | |
ABVX Abivax | Assumes: Equal-Weight | 12 | 77 | -84.42% | 1 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 24 | 8.78 | 173.35% | 2 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 31 22 | 32.21 | -31.7% | 3 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 6 | 7.07 | -15.13% | 2 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 106 | 71.78 | 47.67% | 2 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 11.84 | 195.61% | 1 | Oct 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 2.08 | 525% | 1 | Apr 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 3 | 2.42 | 23.97% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 | 2.97 | 1246.8% | 8 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | n/a | n/a | 3 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.53 | 749.67% | 5 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 46.95 | -36.1% | 8 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 23 | 19.54 | 17.71% | 5 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 50 | 50.58 | -1.15% | 9 | Jul 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 141 | 19.72 | 615.01% | 13 | Jun 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 156 | 17.16 | 809.09% | 5 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 9 | 4.5 | 100% | 5 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 138 | n/a | n/a | 6 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 21 22 | 25.07 | -12.25% | 2 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 6.01 | 16.47% | 3 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 1 | n/a | n/a | 4 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | 6.86 | 16.62% | 5 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 24.95 | 84.37% | 5 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 7 | 2.15 | 225.58% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 51 55 | 15.9 | 245.91% | 3 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 131.65 | -65.06% | 1 | Feb 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 4 | n/a | n/a | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 10 | n/a | n/a | 2 | Oct 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 101.43 | -51.69% | 4 | Nov 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 328 370 | 953.89 | -61.21% | 2 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 31 | 77.67 | -60.09% | 6 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 76 | 79.89 | -4.87% | 8 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 182 | 111.92 | 62.62% | 6 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 107 | 112.9 | -5.23% | 13 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 90 95 | 132.22 | -28.15% | 10 | Jul 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 18 | 19.41 | -7.26% | 1 | Jul 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 93 116 | 141.53 | -18.04% | 12 | Jun 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 38 | 97.61 | -61.07% | 4 | May 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 22 | 145.97 | -84.93% | 1 | May 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 33 35 | 69.01 | -49.28% | 9 | Apr 29, 2020 |